TTPH : Summary for Tetraphase Pharmaceuticals, Inc - Yahoo Finance

U.S. Markets closed

Tetraphase Pharmaceuticals, Inc. (TTPH)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.40+0.22 (+5.26%)
At close: 4:00 PM EST
People also watch:
CEMPCMRXESPRPTCTZFGN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close4.18
Open4.18
Bid4.02 x 300
Ask4.95 x 1200
Day's Range4.14 - 4.45
52 Week Range3.11 - 10.92
Volume297,595
Avg. Volume341,255
Market Cap162.38M
Beta2.63
PE Ratio (TTM)-2.20
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire16 days ago

    Tetraphase Publishes Phase 3 IGNITE1 Eravacycline Data in JAMA Surgery

    WATERTOWN, Mass., Nov. 17, 2016-- Tetraphase Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant infections, today ...

  • Capital Cube23 days ago

    ETF’s with exposure to Tetraphase Pharmaceuticals, Inc. : November 10, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Tetraphase Pharmaceuticals, Inc. Here are 5 ETF’s with the largest exposure to TTPH-US. Comparing the performance and risk of Tetraphase Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Tetraphase Pharmaceuticals, Inc. :TTPH-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016
    Capital Cube25 days ago

    Tetraphase Pharmaceuticals, Inc. :TTPH-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016

    Categories: Yahoo Finance Get free summary analysis Tetraphase Pharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Tetraphase Pharmaceuticals, Inc. – Pfizer Inc. and Merck & Co., Inc. (PFE-US and MRK-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 0.85 ... Read more (Read more...)